Health care resource utilization and costs in patients receiving long-acting injectable vs oral antipsychotics: A comparative analysis from the Disease Recovery Evaluation and Modification (DREaM) study

BACKGROUND: Given relapse frequency early in the course of schizophrenia, recently diagnosed patients may benefit from longacting injectable antipsychotics, which are associated with reduced risk of relapse and hospitalization compared with oral antipsychotics (OAPs). OBJECTIVE: To compare health ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Anirban, Benson, Carmela, Turkoz, Ibrahim, Patel, Charmi, Baker, Pamela, Brown, Brianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373019/
https://www.ncbi.nlm.nih.gov/pubmed/36125055
http://dx.doi.org/10.18553/jmcp.2022.28.10.1086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373019/
https://www.ncbi.nlm.nih.gov/pubmed/36125055
http://dx.doi.org/10.18553/jmcp.2022.28.10.1086

Ejemplares similares